Clinical Trial

Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

Enrolling by Invitation Phase 1/2
View on ClinicalTrials.gov →
Summary
Efficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-10; most recent amendment 2026-06-22.
Trial Details
NCT Number NCT07299123
Lead Sponsor Chinese PLA General Hospital
Collaborators: Fourth Medical Center of PLA General Hospital, Beijing 302 Hospital, The First Medical Center of Chinese PLA General Hospital, Pollon Life Co., Ltd., Yan'an University Affiliated Hospital, The University of Hong Kong-Shenzhen Hospital, Beijing Friendship Hospital, Beijing GeniusCure Biotechnology Co., Ltd., Shenzhen University General Hospital
Conditions Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia
Enrollment 40 participants
Start Date 2022-08-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23